Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Danchenko, Natalya
77  Ergebnisse:
Personensuche X
?
1

Predictors of real-world response in adults treated with bo..:

Fheodoroff, Klemens ; Jacinto, Jorge ; Ashford, Stephen...
The Journal of the International Society of Physical and Rehabilitation Medicine.  7 (2024)  1 - p. 24-32 , 2024
Link: https://doi.org/10.1097/..
 
?
2

Cost-effectiveness of abobotulinumtoxinA plus best supporti..:

Moore, Peter ; Danchenko, Natalya ; Weidlich, Diana..
PLOS ONE.  19 (2024)  2 - p. e0296340 , 2024
Link: https://doi.org/10.1371/..
 
?
3

Efficacy of abobotulinumtoxinA versus onabotulinumtoxinA fo..:

Cruz, Francisco ; Danchenko, Natalya ; Fahrbach, Kyle...
Journal of Medical Economics.  26 (2023)  1 - p. 200-207 , 2023
Link: https://doi.org/10.1080/..
 
?
4

A UK Single-Center, Retrospective, Noninterventional Study ..:

Bezzina, Clive ; Degtiar, Vadim ; Danchenko, Natalya...
Toxins.  15 (2023)  9 - p. 532 , 2023
Link: https://doi.org/10.3390/..
 
?
5

Clinical and Economic Outcomes of Adult Limb Spasticity Tre..:

Bezzina, Clive ; Degtiar, Vadim ; Danchenko, Natalya...
Toxicon.  214 (2022)  - p. S8 , 2022
Link: https://doi.org/10.1016/..
 
?
6

Factors Associated With Favorable Response in Real-World Us..:

Jacinto, Jorge ; Ashford, Stephen ; Fheodoroff, Klemens...
Toxicon.  214 (2022)  - p. S26-S27 , 2022
Link: https://doi.org/10.1016/..
 
?
7

Modelling Long-Term Outcomes and Risk of Death for Patients..:

Fheodoroff, Klemens ; Danchenko, Natalya ; Whalen, John...
Journal of Rehabilitation Medicine.  54 (2022)  - p. jrm00303 , 2022
Link: https://doi.org/10.2340/..
 
?
8

The cost-effectiveness of abobotulinumtoxinA (Dysport) and ..:

Danchenko, Natalya ; Johnston, Karissa M. ; Whalen, John
Journal of Medical Economics.  25 (2022)  1 - p. 919-929 , 2022
Link: https://doi.org/10.1080/..
 
?
9

Comparative Efficacy of AbobotulinumtoxinA and Onabotulinum..:

Danchenko, Natalya ; Fahrbach, Kyle ; Freitag, Andreas..
Toxicon.  214 (2022)  - p. S15 , 2022
Link: https://doi.org/10.1016/..
 
?
10

Modelling Long-Term Outcomes and Mortality Risk for Post-St..:

Balcaitiene, Jovita ; Danchenko, Natalya ; Zaffalon, Andrea...
Toxicon.  214 (2022)  - p. S5-S6 , 2022
Link: https://doi.org/10.1016/..
 
?
11

Cost-effectiveness of BoNT-A products for treatment of pedi..:

Danchenko, Natalya ; Johnston, Karissa ; Bolatova, Talshyn.
Toxicon.  190 (2021)  - p. S15 , 2021
Link: https://doi.org/10.1016/..
 
?
12

BoNT-As for adult spasticity and cervical dystonia: Cost-ef..:

Johnston, Karissa ; Danchenko, Natalya ; Bolatova, Talshyn.
Toxicon.  190 (2021)  - p. S35 , 2021
Link: https://doi.org/10.1016/..
 
?
13

Economic outcomes in real-world use of botulinum toxin-A pr..:

Turner-Stokes, Lynne ; Ashford, Stephen ; Jacinto, Jorge...
Toxicon.  190 (2021)  - p. S73 , 2021
Link: https://doi.org/10.1016/..
 
?
14

Cost effectiveness and impact on quality of life of abobotu..:

Johnston, Karissa ; Danchenko, Natalya ; Hansen, Ryan...
Journal of Medical Economics.  23 (2020)  6 - p. 631-640 , 2020
Link: https://doi.org/10.1080/..
 
?
15

Economic evaluation of abobotulinumtoxinA vs onabotulinumto..:

Danchenko, Natalya ; Lundkvist, Jonas ; Lysandropoulos, Andreas.
Neurology.  92 (2019)  15_supplement - p. , 2019
Link: https://doi.org/10.1212/..
 
1-15